Skip to content
Home/Companies/Biotech/Hemerion Therapeutics
HT

Hemerion Therapeutics

Biotech·France·Active·4yr hold

Hemerion Therapeutics is a healthcare company, headquartered in France.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Hemerion Therapeutics?

Hemerion Therapeutics is currently owned by Finovam Gestion through FIRA Nord-Est 2 (2021 vintage), since 2022.

Hand-verified · updated 2026-04-21

Finovam Gestion
Investor
Finovam Gestion
FIRA Nord-Est 2 · 2021 · VC

Key facts

HQFrance
SectorHealthcare

More from FIRA Nord-Est 2

Other portfolio companies in the same fund.

Nahimic
Exited 2018
SoftwareFrance
to
OVERSOC
Active
Parkki
Exited 2022
MobilityFrance
to
Playdigious
Exited 2022
GamingFrance
to
Tiamat
Active
Wavely
Exited 2025
IndustrialsFrance
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings